ESRD patients

Related by string. * ESRS : Nephros ESRD products . Juniper Networks MX# ESR . ESR newsletter . ESR forensic . disease ESRD . Disease ESRD . ESR / Patients . PATIENTS . PATIENT . Patient . pa tients . pa tient : Breast Cancer Patients . terminally ill patients . Patient Safety . Improving Patient Outcomes . chronically ill patients . Patient Centered Medical * Disease ESRD patient *

Related by context. All words. (Click for frequent words.) 64 hemodialysis patients 63 hyperphosphatemia 62 SHPT 61 phosphate binders 60 ADHF 60 serum phosphorus levels 59 CKD Stage 59 serum phosphorus 58 Primary IGFD 58 chronic HBV 58 HCV infected 58 COPAXONE R 58 thromboprophylaxis 58 hepatorenal syndrome 58 cinacalcet 58 phosphate binder 58 glycated hemoglobin levels 57 serum phosphate levels 57 adult chronic ITP 57 chronic ITP patients 57 VTE prophylaxis 57 intravenous diuretics 57 colorectal liver metastases 57 patients undergoing CABG 57 certolizumab 57 CTAP# Capsules 57 heavily pretreated 57 atherogenic dyslipidemia 57 K DOQI 57 serum phosphate 57 HoFH 57 revascularization procedures 57 chronic hemodialysis 57 alemtuzumab treated 56 β blockers 56 relapsed MM 56 elevated triglyceride levels 56 relapsing remitting MS RRMS 56 pancreatic NET 56 comorbid conditions 56 antiarrhythmic drug 56 oral anticoagulation 56 relapsed multiple myeloma 56 aldosterone antagonist 56 hyperphosphataemia 56 RSV infections 56 corticosteroid dose 56 severe aortic stenosis 56 osteoporotic vertebral compression fractures 56 SCIg 56 nondiabetic patients 55 paclitaxel eluting stents 55 ESRD 55 perioperative mortality 55 isolated systolic hypertension 55 hyperphenylalaninemia HPA due 55 chronic HCV infection 55 elevated serum creatinine 55 aortic valve stenosis 55 sevelamer 55 HSCT 55 pulmonary embolism PE 55 LANTUS ® 55 HCV infections 55 antimicrobial prophylaxis 55 pancreatic insufficiency 55 imipenem 55 CYPHER Stent 55 nonalcoholic steatohepatitis NASH 55 AFib 55 comorbid illnesses 55 CKD ND 55 NAFLD 55 octreotide LAR 55 BARACLUDE ® 55 disease ESRD 55 hypertensive patients 55 chronic ITP 55 macroalbuminuria 55 receiving antiretroviral therapy 55 Anticoagulants 55 azacitidine 55 TMP SMX 55 preoperative chemotherapy 55 K DOQI guidelines 55 Ferinject ® 55 ARIXTRA 55 Liver transplantation 55 AAT deficiency 55 post thrombotic syndrome 54 chronic HCV 54 carotid artery stenting 54 subclinical hypothyroidism 54 cirrhotic patients 54 oral iron chelator 54 T2DM 54 stable angina 54 paroxysmal AF 54 FOSRENOL ® 54 relapsed AML 54 gonococcal infections 54 glucocorticoid therapy 54 VTE 54 perioperative morbidity 54 cytoreduction 54 HbA1c levels 54 anticoagulation therapy 54 sunitinib 54 symptomatic BPH 54 Acute Myocardial Infarction AMI 54 pulmonary exacerbations 54 SJIA 54 vertebral compression fractures 54 NSTE ACS 54 deferasirox 54 cIAI 54 malignant pleural mesothelioma 54 overt nephropathy 54 trials RCTs 54 Doxil ® 54 oral antidiabetic medication 54 uncontrolled asthma 53 anemia hemoglobin 53 microalbuminuria 53 autoantibody positive 53 beta blocker therapy 53 candidemia 53 Hb A1C 53 liver transplant recipients 53 REMICADE ® 53 RBC transfusions 53 polyp recurrence 53 invasive aspergillosis 53 metastatic neuroendocrine tumors 53 endometrial hyperplasia 53 decompensated heart failure 53 thrombocytopenic 53 GORE VIABAHN Endoprosthesis 53 CMV disease 53 warfarin therapy 53 NATRECOR R 53 Myelodysplastic syndromes MDS 53 carcinoid tumors 53 symptomatic fibroids 53 HeFH 53 Severe VOD 53 OAB symptoms 53 cirrhosis liver failure 53 AA Amyloidosis 53 renal tumors 53 lupus renal disease 53 Hydroxyurea 53 serum phosphorous 53 systemic corticosteroids 53 cancer cachexia 53 AV fistulas 53 lanthanum carbonate 53 antibiotic regimens 53 indolent NHL 53 mycophenolate mofetil 53 CMV infection 53 ulcerative colitis UC 53 peginterferon alfa 2a 53 ICD therapy 53 CDAD 53 co morbidities 53 Rectal cancer 53 atherothrombotic disease 53 colorectal cancer CRC 53 intracranial hemorrhage ICH 53 NNT = 53 corticosteroid therapy 53 severe sepsis 53 glomerular filtration rate 53 symptomatic aortic stenosis 53 UA NSTEMI 53 HIV HCV coinfected 53 serum creatinine levels 53 thromboembolic 53 bosentan 53 chronic hepatitis C. 53 diabetic nephropathy 53 PCIs 53 osteoporotic fractures 53 dosage regimens 53 EDSS scores 53 venous thromboembolism 53 chronic kidney 53 hepatic resection 53 poor metabolizers 53 medullary thyroid cancer 53 Chronic hepatitis C 53 Hepatocellular Carcinoma HCC 53 mRCC 53 COPD 53 antihypertensive therapy 53 iron chelation 53 heterozygous FH 53 Nesiritide 53 secondary hyperparathyroidism 53 lipid lowering therapy 53 MitraClip device 53 bezafibrate 53 peginterferon 53 aortic stenosis 52 fallopian tube carcinoma 52 treat hyperphosphatemia 52 epoetin alfa 52 acute STEMI 52 systemic immunosuppressive drugs 52 allogeneic bone marrow 52 CrCl 52 ischemic cardiomyopathy 52 allogeneic HSCT 52 ALND 52 rFVIIa 52 Benign Prostatic Hyperplasia BPH 52 APTIVUS r 52 Critical Limb Ischemia CLI 52 antiplatelet drugs 52 Octreolin 52 Pulmonary Arterial Hypertension PAH 52 sustained virological response 52 immunosuppressive therapies 52 vitamin D insufficiency 52 pancreatic adenocarcinoma 52 calcineurin inhibitors 52 RSV infection 52 calcineurin inhibitor 52 carotid stenting 52 antiplatelet medications 52 Fabry Disease 52 recurrent VTE 52 refractory angina 52 hypercalcemia 52 lipid lowering drugs 52 chronic angina 52 InterStim Therapy 52 macrovascular events 52 Renal Cell Carcinoma RCC 52 coronary blockages 52 HbA 1c 52 atherothrombosis 52 hyperglycaemia 52 statin therapy 52 vandetanib 52 nonvertebral fracture 52 dalteparin 52 antihypertensive drugs 52 Cytoxan 52 Fluid retention 52 allogeneic stem cell 52 relapsed SCLC 52 antithrombotic therapy 52 upper gastrointestinal bleeding 52 nonalcoholic steatohepatitis 52 metastatic lung cancer 52 aldosterone antagonists 52 invasive fungal infections 52 hepatitis C genotype 52 prostate TURP 52 interferon alfa 52 chronic HBV infection 52 Fibrillex TM 52 ketorolac 52 T1DM 52 bowel resection 52 Carotid endarterectomy 52 fluvastatin 52 GERD sufferers 52 coronary revascularization 52 chronic immune thrombocytopenic 52 CIMZIA ™ 52 elevated LDL cholesterol 52 smoldering multiple myeloma 52 chronic GVHD 52 dose escalation phase 52 oral anticoagulants 52 renal dysfunction 52 diastolic heart 52 hemodialysis peritoneal dialysis 52 immunomodulatory therapy 52 anagrelide 52 ZYVOX 52 NeuroStar TMS Therapy 52 LNG IUS 52 acute coronary syndromes ACS 52 hypoparathyroidism 52 tuberculin skin testing 52 chronic renal disease 52 cardiovascular hospitalization 52 severe renal impairment 52 acute myocardial infarction AMI 52 graft dysfunction 52 iron chelation therapy 52 virological response 52 dyslipidaemia 52 complete cytogenetic response 52 Lung transplantation 52 antithrombotics 52 renal impairment 52 bardoxolone methyl 52 AAT Deficiency 52 carotid stenosis 52 glycemic variability 52 EDARBI 52 OHR/AVR# 52 coronary revascularization procedures 52 clodronate 52 gallstone disease 52 forodesine 52 CABG surgeries 52 IFN beta 52 virus HCV infection 52 parenteral nutrition 52 Kepivance 52 acute ischemic stroke 52 ADPKD 52 Aortic stenosis 52 Diabetic Macular Edema 51 biologic DMARD 51 inotropic 51 osteoporotic compression fractures 51 Acute Coronary Syndromes ACS 51 postoperative atrial fibrillation 51 riociguat 51 lupus nephritis 51 Chronic hepatitis B 51 Overactive Bladder 51 fondaparinux 51 basal cell nevus syndrome 51 HCV infection 51 iPTH 51 multivessel disease 51 HoLEP 51 Severe Primary IGFD 51 NSAID therapy 51 leukemia AML 51 tolvaptan 51 S. aureus infections 51 underwent resection 51 ximelagatran 51 awaiting kidney transplants 51 dosing intervals 51 thrombotic events 51 Kidney Disease Outcomes 51 candesartan 51 radical nephrectomy 51 LEUKINE 51 creatinine clearance 51 mL/min/#.# m2 51 ruptured aneurysms 51 immunosuppressive regimen 51 tuberous sclerosis TS 51 hemoglobin A1c levels 51 Coronary Artery Bypass Graft 51 Kidney transplantation 51 STEMI patients 51 HAART regimens 51 IRESSA 51 proliferative diabetic retinopathy 51 NPH insulin 51 thoracoscopic lobectomy 51 bisphosphonate therapy 51 nephron sparing surgery 51 antiplatelet therapies 51 severe exacerbations 51 unresectable liver cancer 51 cisplatin chemotherapy 51 dyslipidemic 51 olmesartan 51 COPD exacerbations 51 elective PCI 51 combination antiretroviral therapy 51 salmeterol fluticasone 51 GnRH agonists 51 postoperative morbidity 51 Diabetic nephropathy 51 dacarbazine 51 metastatic GIST 51 thyrotropin levels 51 RRMS patients 51 EDSS score 51 eprotirome 51 LQTS 51 antibiotic prophylaxis 51 C. difficile colitis 51 ATACAND 51 fasting triglyceride levels 51 APTIVUS 51 juvenile idiopathic arthritis JIA 51 IOP lowering 51 vWD 51 myocardial infarctions 51 cardiac dysfunction 51 ritonavir boosted lopinavir 51 lomitapide 51 plasminogen activators 51 pharmacologic intervention 51 radioiodine therapy 51 elevated CRP 51 pyridostigmine 51 hypertensives 51 serum lipid levels 51 Hyperlipidemia 51 biologic therapy 51 lipid lowering medication 51 adrenalectomy 51 NAbs 51 posaconazole 51 ACTEMRA TM 51 thiazide diuretics 51 acute PAO 51 Chronic HCV 51 androgen deficiency 51 noninfectious uveitis 51 Osteoarthritis OA 51 MYCAMINE 51 EXJADE 51 Shire Fosrenol 51 chronic hepatitis cirrhosis 51 drug ISA# 51 Vitamin B# deficiency 51 oropharyngeal candidiasis 51 hemoglobin A1c HbA1c 51 Non Alcoholic Fatty 51 renal insufficiency 51 aromatase inhibitors AIs 51 infective endocarditis 51 PSADT 51 refractory AML 51 hypervolemic hyponatremia 51 antihypertensive medication 51 hour bronchodilation 51 DVT PE 51 A1c levels 51 thrombocytopenic patients 51 nephrologists 51 Hp2 2 51 oral bisphosphonates 51 hyperkalemia 51 coronary intervention 51 chemotherapeutic regimens 51 LMWH 51 ALI ARDS 51 Mimpara 51 recurrent glioblastoma multiforme 51 VIAject 51 adalimumab 51 elevated uric acid 51 oral rivaroxaban 51 PREZISTA r 51 titrated glipizide 51 superficial bladder cancer 51 Dabigatran 51 nicardipine 51 AZOR 51 milrinone 51 macrovascular disease 51 systolic hypertension 51 thrombolytic agents 51 HBV vaccination 51 fluoroquinolone resistance 51 eculizumab therapy 51 CRVO 51 AA amyloidosis 51 artery calcification 51 gout flares 51 antihypertensive medications 51 onset atrial fibrillation 51 temsirolimus 51 nonpregnant adults 51 Chronic Heart Failure 51 levodopa therapy 50 hemodynamically stable 50 mechanically ventilated patients 50 AGILECT R 50 Natalizumab 50 phosphate binder therapy 50 treated nonsurgically 50 Renal dysfunction 50 suboptimal adherence 50 TYSABRI natalizumab 50 peritoneal dialysis PD 50 FOLFOX4 50 HbA1C 50 Neovascular Age Related Macular 50 microvascular complications 50 Microplasmin 50 underwent liver transplantation 50 noncardiovascular mortality 50 conventional angiography 50 hepatocellular carcinoma 50 coronary interventions 50 deferiprone 50 venous reflux 50 patients undergoing percutaneous 50 renal transplants 50 microvascular disease 50 Atypical Hemolytic Uremic Syndrome 50 iron overload 50 cholinesterase inhibitor 50 loop diuretics 50 Acute renal failure 50 VAPRISOL 50 QVAR R 50 anticoagulant warfarin 50 asymptomatic carotid stenosis 50 Surgical resection 50 osteoporotic fracture 50 Chronic lymphocytic leukemia 50 NYHA Class II 50 sulphonylureas 50 pouchitis 50 HbF 50 Dasatinib 50 Hib disease 50 invasive candidiasis 50 virological suppression 50 improves glycemic 50 severe mitral regurgitation 50 noncardiac surgery 50 prospectively enrolled 50 immunosuppressive medications 50 renal transplantation 50 IV NSCLC 50 paricalcitol 50 renal denervation 50 conventional coronary angiography 50 chronic thromboembolic pulmonary 50 renal cell carcinomas 50 smoldering myeloma 50 Juvenile Idiopathic Arthritis 50 immunosuppressive regimens 50 mitral regurgitation MR 50 Kaplan Meier estimate 50 limb salvage 50 dialysis CKD 50 nonsurgical treatments 50 lipid lowering medications 50 bone metastases 50 dyslipidemia 50 salmeterol fluticasone propionate 50 preserved ejection fraction 50 nocturnal hemodialysis 50 soft tissue sarcomas 50 PREZISTA rtv 50 NOMID 50 Ventricular Assist Devices 50 herpetic keratitis 50 fluid overload 50 bladder augmentation 50 experienced virologic failure 50 placebo dexamethasone 50 fragility fracture 50 protease inhibitor PI 50 levosimendan 50 carotid surgery 50 irbesartan 50 cytoreductive surgery 50 advanced neoplasia 50 latent TB infection 50 Chronic HCV infection 50 Exjade 50 warfarin 50 lipid lowering therapies 50 fragility fractures 50 mildly symptomatic 50 transferrin saturation 50 fosamprenavir 50 de aths 50 primary hypercholesterolemia 50 chronic idiopathic thrombocytopenic purpura 50 hyperuricemia 50 haematologic malignancies 50 NSTEMI 50 atrial fibrillation AFib 50 TAXUS stents 50 artery stenosis 50 hepatectomy 50 ibandronate 50 colorectal cancer incidence 50 relapsing MS 50 NYHA Class III 50 intravesical therapy 50 critical limb ischemia 50 LTBI 50 Critical limb ischemia 50 renal artery stenosis 50 DETROL LA 50 anticlotting drugs 50 fibrinolytic therapy 50 bendamustine 50 terlipressin 50 COPAXONE ® 50 systemic corticosteroid 50 carotid stents 50 hydroxyvitamin D levels 50 NYHA functional class 50 allogeneic hematopoietic stem cell 50 Losartan 50 immunosuppressed 50 Myelodysplastic syndromes 50 Hyperphosphatemia 50 ofpatients 50 Naive Patients 50 treat NNT 50 ejection fractions 50 Advagraf 50 serum IGF 50 Hizentra 50 Peripheral Artery Disease 50 RYGB 50 anticoagulation 50 undergoing coronary artery 50 cytopenias 50 intermittent claudication 50 coinfected patients 50 BARACLUDE 50 acid suppressive medication 50 AVELOX 50 renal function 50 valsartan amlodipine 50 skeletal metastases 50 functional mitral regurgitation 50 mixed hyperlipidemia 50 empyema 50 urolithiasis 50 symptomatic paroxysmal AF 50 CoreValve System 50 testosterone supplementation 50 abacavir lamivudine 50 chemoradiotherapy 50 acute coronary syndromes 50 Xanafide 50 Hypotension 50 prehypertensive 50 malignant pleural mesothelioma MPM 50 Angiox R 50 liver transplantation 50 metastatic RCC 50 therapeutic regimens 50 chronic periodontitis 50 metformin Glucophage 50 timepoints 50 overactive bladder syndrome 50 Chronic Kidney Disease 50 somatostatin analogs 50 cardiovascular mortality 50 insulin detemir 50 inotropes 50 left ventricular dysfunction 50 Premature infants 50 perioperatively 50 vasopressor 50 TORISEL 50 colorectal adenoma 50 atherosclerotic disease 50 rilonacept 50 Pulmonary Arterial Hypertension 50 Prehypertension 50 CLL cells 50 non metastatic osteosarcoma 50 LEXIVA r 50 comorbidities 50 secondary hyperparathyroidism SHPT 50 tipranavir 50 decitabine 50 efalizumab 50 PROLASTIN 50 inhaled corticosteroid therapy 50 nephrolithiasis 50 amoxicillin clavulanate 50 diabetic retinopathy DR 50 OSAHS 50 intensive statin therapy 50 standard chemotherapy regimen 50 transplantation HCT 50 co trimoxazole 50 carotid artery stenting CAS 50 virologic suppression 50 PAOD 50 postsurgical 50 acute GvHD 50 systemic hypotension 50 cholangiocarcinoma 50 type2 diabetes 50 CIMZIA TM certolizumab pegol 49 lower extremity amputations 49 bolus dose 49 Dialysis Outcomes 49 COREG 49 Peripheral arterial disease 49 endarterectomy 49 deferoxamine 49 prescribed statins 49 bronchial thermoplasty 49 symptomatic carotid stenosis 49 interstitial brachytherapy 49 TandemHeart 49 hereditary deficiency 49 emergency departments EDs 49 severe Primary IGFD 49 Celiac disease affects 49 hypercholesterolaemia 49 SUTENT 49 colectomy 49 dose cytarabine 49 SSTIs 49 glomerular filtration 49 TEMODAL 49 hemodynamic instability 49 non splenectomized 49 eosinophilic asthma 49 acute coronary syndrome 49 Combination therapy 49 retrospective cohort 49 chronic hepatitis B. 49 Follicular Lymphoma 49 aHUS 49 Secondary Hyperparathyroidism 49 MGUS 49 hyperglycemia 49 mealtime insulin 49 lumiliximab 49 intravenous bisphosphonates 49 thiazides 49 antiepileptic drug 49 Critical Limb Ischemia 49 untreated celiac disease 49 MTWA testing 49 gastrointestinal GI motility disorders 49 PSA nadir 49 tissue oxygenation 49 folate supplementation 49 Gleevec imatinib 49 MULTAQ 49 Acute Coronary Syndromes 49 myelofibrosis 49 Gliadel Wafer 49 stem cell transplantations 49 virologic failure 49 progressive PsA 49 invasive fungal infection 49 sunitinib malate 49 HCV 49 Tolvaptan 49 pegylated interferon alpha 49 angiotensin converting enzyme inhibitors 49 XIENCE V stent 49 HbA1c 49 bariatric surgeries performed 49 angiotensin receptor blockers 49 lipohypertrophy 49 Epoetin alfa 49 octreotide 49 osteoporotic vertebral fractures 49 ALT flares 49 Tumors shrank 49 Advagraf R 49 cotrimoxazole 49 anthracycline therapy 49 underwent bariatric surgery 49 antireflux surgery 49 R0 resection 49 H. pylori infection 49 NNRTI resistance 49 vinorelbine 49 herpes zoster vaccine 49 Spectranetics laser 49 chronic hepatitis B 49 glycemic control 49 trastuzumab Herceptin ® 49 haemorrhagic stroke 49 genital HSV 49 nitazoxanide 49 glulisine 49 severe hypoglycaemia 49 adalimumab Humira 49 psoriatic arthritis PsA 49 pitavastatin 49 Gamma Knife surgery 49 failure ADHF 49 tumor resection 49 epoetin 49 pegfilgrastim 49 Soliris therapy 49 Pulmonary hypertension 49 sustained virologic response 49 platinum refractory 49 intracerebral hemorrhage 49 VIDAZA 49 venous blood clots 49 hepatitis B immunoglobulin 49 atrophic gastritis 49 malignant neoplasms 49 juvenile idiopathic arthritis 49 antiplatelet therapy 49 interferon therapy 49 Bronchiectasis 49 ICD implantation 49 MPS VI 49 teriparatide 49 HBeAg negative 49 unstable angina UA 49 continuous ambulatory peritoneal 49 chemoradiation therapy 49 tumor lysis syndrome 49 tacrolimus ointment 49 cardiovascular morbidity 49 dyslipidemic patients 49 Chronic Idiopathic Constipation 49 interferon ribavirin 49 obese adolescents 49 inhaled iloprost 49 NYHA Class 49 romiplostim 49 uncontrolled hypertension 49 concomitant AEDs 49 urinary symptoms 49 vasomotor symptoms 49 MACCE 49 abatacept 49 pneumococcal pneumonia 49 BrachySil TM 49 metastatic renal cell carcinoma 49 INTERCEPT platelets 49 purpura ITP 49 mucosal healing 49 Vascugel 49 Torisel 49 hysterectomies performed 49 Diabetes Mellitus 49 Peginterferon 49 dietary sodium 49 myelofibrosis MF 49 Vitamin D supplementation 49 genital HPV infections 49 venous ulcers 49 IPAH 49 nucleoside naive patients 49 subependymal giant cell 49 MabCampath 49 ablation procedures 49 pegylated interferon alfa 49 Chronic sinusitis 49 Severe Sepsis 49 Major Depressive Disorder 49 alvimopan 49 chemotherapy induced neutropenia 49 mitoxantrone 49 angiotensin receptor blockers ARBs 49 mixed dyslipidemia 49 metastatic brain tumor 49 severe renal insufficiency 49 oral antidiabetics 49 neurogenic orthostatic hypotension 49 grade gliomas 49 laser atherectomy 49 rhGH 49 glatiramer acetate 49 chronic rhinosinusitis 49 ICDs implanted 49 ECD kidneys 49 undergo spinal fusion 49 familial hypercholesterolemia 49 postoperative mortality 49 Vitamin D insufficiency 49 nonfasting triglyceride levels 49 C. difficile infections 49 nonmelanoma skin cancer 49 systolic dysfunction 49 serum triglyceride levels 49 ST Elevation Myocardial 49 Aprotinin 49 Preterm infants 49 orthostatic hypotension 49 interventional therapies 49 ischemic strokes 49 fluticasone salmeterol 49 ocular hypertension 49 pan HDAC inhibitor 49 magnesium intake 49 prenatal multivitamin 49 TheraSphere 49 von Willebrand disease 49 Fibrates 49 abnormal lipids 49 virologic response 49 biliary tract cancer 49 advanced NSCLC 49 relapsed refractory multiple myeloma 49 postoperative AF 49 fibrin deposition 49 underwent CABG 49 receiving lifesaving antiretroviral 49 6R BH4 49 INCB# [001] 49 IFN alfa 49 Eligen R B# 49 Rheumatoid arthritis affects 49 HBV infections 49 generalized edema 49 undetectable viral 49 tocilizumab 49 pulmonary hypertension PH 49 tacrolimus 49 refractory gout 49 Trevor Mundel MD 49 atypical antipsychotic medications 49 liver scarring 49 CLA supplementation 49 TNF antagonist 49 pegylated liposomal doxorubicin 49 intravascular volume 49 rotavirus diarrhea 49 diabetic kidney 49 Myelodysplastic Syndrome MDS 49 kidney dysfunction 49 HCV genotype 1 49 unresectable tumors 49 thrombus aspiration 49 amphotericin B 49 steroid dexamethasone 49 anterior uveitis 49 severe hypoglycemic 49 Jevtana 49 OADs 49 Chronic kidney 49 nesiritide 49 Statin therapy 49 antiretroviral medications 49 pediatric rheumatologists 49 alteplase 49 drug eluting stent DES 49 carotid artery stenosis 48 dose Iluvien 48 atherothrombotic events 48 adjuvant radiation 48 glycemia 48 RBC transfusion 48 uremic pruritus 48 homozygous familial hypercholesterolemia 48 NAVISTAR R 48 pramlintide 48 recurrent glioblastoma 48 Exacerbations 48 either acutely decompensated 48 castrate resistant prostate cancer 48 CRBSIs 48 cardiovascular disease CVD 48 acutely decompensated congestive heart 48 frequent blood transfusions 48 Vivaglobin 48 thrombolytic therapy 48 antidiabetic therapy 48 Fludara 48 dialysis catheters 48 external beam radiotherapy 48 duodenal ulcer 48 cerebral infarction 48 NIASPAN 48 PrandiMet TM 48 severe asthma exacerbations 48 KIACTA ™ 48 acute myelogenous leukemia AML 48 hematopoietic cell 48 calcium oxalate stones 48 opioid analgesia 48 coronary artery revascularization 48 bioprostheses 48 CIPN 48 retinal vein occlusion 48 antiretroviral therapy 48 DMARDs 48 transfusion syndrome 48 Etanercept 48 severe neutropenia 48 postoperative complication 48 ZOSTAVAX 48 intravitreal injections 48 autonomic dysfunction 48 invasive MRSA infections 48 inadequate glycemic 48 Pegylated Interferon 48 extrapyramidal symptoms 48 liver resection 48 subclinical hyperthyroidism 48 idiopathic pulmonary fibrosis IPF 48 latent celiac disease 48 venous thromboembolism VTE 48 virologic 48 acute myocardial infarctions 48 velafermin 48 clopidogrel 48 knee osteoarthritis OA 48 HNSCC 48 overactive bladder OAB 48 benazepril

Back to home page